nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—HRH1—atherosclerosis	0.522	1	CbGaD
Fluphenazine—CYP2D6—Niacin—atherosclerosis	0.0305	0.149	CbGbCtD
Fluphenazine—ABCB1—Ezetimibe—atherosclerosis	0.0275	0.134	CbGbCtD
Fluphenazine—ABCB1—Simvastatin—atherosclerosis	0.0256	0.125	CbGbCtD
Fluphenazine—ABCB1—Lovastatin—atherosclerosis	0.025	0.122	CbGbCtD
Fluphenazine—ABCB1—Pravastatin—atherosclerosis	0.025	0.122	CbGbCtD
Fluphenazine—CYP2D6—Simvastatin—atherosclerosis	0.0241	0.118	CbGbCtD
Fluphenazine—CYP2D6—Pravastatin—atherosclerosis	0.0236	0.115	CbGbCtD
Fluphenazine—CYP2D6—Lovastatin—atherosclerosis	0.0236	0.115	CbGbCtD
Fluphenazine—HTR2A—arteriole—atherosclerosis	0.00337	0.13	CbGeAlD
Fluphenazine—Creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00316	0.0272	CcSEcCtD
Fluphenazine—Creatine phosphokinase increased—Lovastatin—atherosclerosis	0.00267	0.0231	CcSEcCtD
Fluphenazine—Creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.00262	0.0226	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Lovastatin—atherosclerosis	0.00254	0.0219	CcSEcCtD
Fluphenazine—Creatine phosphokinase increased—Simvastatin—atherosclerosis	0.0025	0.0216	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00241	0.0208	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Simvastatin—atherosclerosis	0.00238	0.0205	CcSEcCtD
Fluphenazine—Creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00226	0.0195	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Pravastatin—atherosclerosis	0.00215	0.0185	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.00204	0.0176	CcSEcCtD
Fluphenazine—HTR2A—vein—atherosclerosis	0.00201	0.0778	CbGeAlD
Fluphenazine—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.002	0.0173	CcSEcCtD
Fluphenazine—Blood disorder—Rosuvastatin—atherosclerosis	0.00199	0.0171	CcSEcCtD
Fluphenazine—Libido increased—Niacin—atherosclerosis	0.00198	0.0171	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00191	0.0165	CcSEcCtD
Fluphenazine—Laryngeal oedema—Niacin—atherosclerosis	0.00188	0.0162	CcSEcCtD
Fluphenazine—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00173	0.0149	CcSEcCtD
Fluphenazine—Tenderness—Lovastatin—atherosclerosis	0.00161	0.0139	CcSEcCtD
Fluphenazine—Glaucoma—Niacin—atherosclerosis	0.0016	0.0138	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Lovastatin—atherosclerosis	0.0016	0.0138	CcSEcCtD
Fluphenazine—Tenderness—Simvastatin—atherosclerosis	0.00151	0.013	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Simvastatin—atherosclerosis	0.0015	0.0129	CcSEcCtD
Fluphenazine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00148	0.0128	CcSEcCtD
Fluphenazine—Hepatocellular injury—Ezetimibe—atherosclerosis	0.00138	0.0119	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Niacin—atherosclerosis	0.00137	0.0119	CcSEcCtD
Fluphenazine—Tenderness—Pravastatin—atherosclerosis	0.00136	0.0118	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00135	0.0117	CcSEcCtD
Fluphenazine—CALM2—artery—atherosclerosis	0.00135	0.0523	CbGeAlD
Fluphenazine—CALM1—artery—atherosclerosis	0.00134	0.052	CbGeAlD
Fluphenazine—HTR2A—hindlimb—atherosclerosis	0.00134	0.0517	CbGeAlD
Fluphenazine—Hepatocellular injury—Simvastatin—atherosclerosis	0.00132	0.0113	CcSEcCtD
Fluphenazine—Renal failure acute—Rosuvastatin—atherosclerosis	0.0013	0.0113	CcSEcCtD
Fluphenazine—Gynaecomastia—Lovastatin—atherosclerosis	0.00126	0.0109	CcSEcCtD
Fluphenazine—Hepatocellular injury—Pravastatin—atherosclerosis	0.00119	0.0103	CcSEcCtD
Fluphenazine—Gynaecomastia—Simvastatin—atherosclerosis	0.00118	0.0101	CcSEcCtD
Fluphenazine—Photosensitivity—Lovastatin—atherosclerosis	0.00116	0.01	CcSEcCtD
Fluphenazine—HTR2A—appendage—atherosclerosis	0.00115	0.0444	CbGeAlD
Fluphenazine—CALM2—endothelium—atherosclerosis	0.00114	0.0442	CbGeAlD
Fluphenazine—Photosensitivity—Ezetimibe—atherosclerosis	0.00114	0.00983	CcSEcCtD
Fluphenazine—CALM1—endothelium—atherosclerosis	0.00113	0.0439	CbGeAlD
Fluphenazine—Urine output increased—Niacin—atherosclerosis	0.00109	0.00942	CcSEcCtD
Fluphenazine—Photosensitivity—Simvastatin—atherosclerosis	0.00109	0.00938	CcSEcCtD
Fluphenazine—Gynaecomastia—Pravastatin—atherosclerosis	0.00106	0.00918	CcSEcCtD
Fluphenazine—Eczema—Simvastatin—atherosclerosis	0.00106	0.00916	CcSEcCtD
Fluphenazine—CALM2—blood vessel—atherosclerosis	0.00105	0.0407	CbGeAlD
Fluphenazine—CALM1—blood vessel—atherosclerosis	0.00105	0.0405	CbGeAlD
Fluphenazine—Polyuria—Niacin—atherosclerosis	0.000998	0.00861	CcSEcCtD
Fluphenazine—Photosensitivity—Pravastatin—atherosclerosis	0.000983	0.00848	CcSEcCtD
Fluphenazine—Eczema—Niacin—atherosclerosis	0.000975	0.00841	CcSEcCtD
Fluphenazine—Renal failure acute—Pravastatin—atherosclerosis	0.000935	0.00806	CcSEcCtD
Fluphenazine—Eosinophilia—Lovastatin—atherosclerosis	0.000873	0.00753	CcSEcCtD
Fluphenazine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00087	0.0075	CcSEcCtD
Fluphenazine—Eosinophilia—Ezetimibe—atherosclerosis	0.000857	0.00739	CcSEcCtD
Fluphenazine—HTR2A—artery—atherosclerosis	0.000818	0.0317	CbGeAlD
Fluphenazine—Eosinophilia—Simvastatin—atherosclerosis	0.000817	0.00705	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000805	0.00694	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000804	0.00694	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00079	0.00681	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000767	0.00661	CcSEcCtD
Fluphenazine—Aceprometazine—HRH1—atherosclerosis	0.000759	0.136	CrCbGaD
Fluphenazine—Dysphagia—Niacin—atherosclerosis	0.000758	0.00653	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000753	0.0065	CcSEcCtD
Fluphenazine—Eosinophilia—Pravastatin—atherosclerosis	0.000739	0.00637	CcSEcCtD
Fluphenazine—Methdilazine—HRH1—atherosclerosis	0.000703	0.126	CrCbGaD
Fluphenazine—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000693	0.00598	CcSEcCtD
Fluphenazine—HTR2A—endothelium—atherosclerosis	0.000691	0.0268	CbGeAlD
Fluphenazine—Oedema peripheral—Ezetimibe—atherosclerosis	0.000682	0.00588	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000681	0.00587	CcSEcCtD
Fluphenazine—Angioedema—Rosuvastatin—atherosclerosis	0.000663	0.00572	CcSEcCtD
Fluphenazine—HTR2A—blood vessel—atherosclerosis	0.000638	0.0247	CbGeAlD
Fluphenazine—Erythema—Ezetimibe—atherosclerosis	0.000603	0.0052	CcSEcCtD
Fluphenazine—Oedema peripheral—Niacin—atherosclerosis	0.000597	0.00515	CcSEcCtD
Fluphenazine—Muscle spasms—Lovastatin—atherosclerosis	0.000591	0.0051	CcSEcCtD
Fluphenazine—Muscle spasms—Ezetimibe—atherosclerosis	0.00058	0.005	CcSEcCtD
Fluphenazine—Vision blurred—Lovastatin—atherosclerosis	0.000579	0.005	CcSEcCtD
Fluphenazine—Erythema—Simvastatin—atherosclerosis	0.000575	0.00496	CcSEcCtD
Fluphenazine—Angioedema—Lovastatin—atherosclerosis	0.000562	0.00484	CcSEcCtD
Fluphenazine—Muscle spasms—Simvastatin—atherosclerosis	0.000553	0.00477	CcSEcCtD
Fluphenazine—Angioedema—Ezetimibe—atherosclerosis	0.000551	0.00475	CcSEcCtD
Fluphenazine—Leukopenia—Lovastatin—atherosclerosis	0.00055	0.00475	CcSEcCtD
Fluphenazine—Vision blurred—Simvastatin—atherosclerosis	0.000542	0.00467	CcSEcCtD
Fluphenazine—CALM2—connective tissue—atherosclerosis	0.000539	0.0209	CbGeAlD
Fluphenazine—CALM1—connective tissue—atherosclerosis	0.000537	0.0208	CbGeAlD
Fluphenazine—Erythema—Niacin—atherosclerosis	0.000528	0.00455	CcSEcCtD
Fluphenazine—CALM3—adipose tissue—atherosclerosis	0.000527	0.0204	CbGeAlD
Fluphenazine—Angioedema—Simvastatin—atherosclerosis	0.000525	0.00453	CcSEcCtD
Fluphenazine—Hypertension—Ezetimibe—atherosclerosis	0.00052	0.00449	CcSEcCtD
Fluphenazine—Leukopenia—Simvastatin—atherosclerosis	0.000515	0.00444	CcSEcCtD
Fluphenazine—Dry mouth—Lovastatin—atherosclerosis	0.000512	0.00441	CcSEcCtD
Fluphenazine—Muscle spasms—Niacin—atherosclerosis	0.000507	0.00438	CcSEcCtD
Fluphenazine—Constipation—Rosuvastatin—atherosclerosis	0.000506	0.00437	CcSEcCtD
Fluphenazine—Dry mouth—Ezetimibe—atherosclerosis	0.000502	0.00433	CcSEcCtD
Fluphenazine—Anaphylactic shock—Lovastatin—atherosclerosis	0.000502	0.00433	CcSEcCtD
Fluphenazine—Muscle spasms—Pravastatin—atherosclerosis	0.0005	0.00431	CcSEcCtD
Fluphenazine—Vision blurred—Niacin—atherosclerosis	0.000497	0.00429	CcSEcCtD
Fluphenazine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000492	0.00424	CcSEcCtD
Fluphenazine—Vision blurred—Pravastatin—atherosclerosis	0.00049	0.00423	CcSEcCtD
Fluphenazine—Angioedema—Niacin—atherosclerosis	0.000482	0.00416	CcSEcCtD
Fluphenazine—Skin disorder—Ezetimibe—atherosclerosis	0.000478	0.00412	CcSEcCtD
Fluphenazine—HTR1A—cardiovascular system—atherosclerosis	0.000477	0.0185	CbGeAlD
Fluphenazine—Angioedema—Pravastatin—atherosclerosis	0.000475	0.0041	CcSEcCtD
Fluphenazine—Leukopenia—Niacin—atherosclerosis	0.000472	0.00408	CcSEcCtD
Fluphenazine—Urticaria—Rosuvastatin—atherosclerosis	0.00047	0.00406	CcSEcCtD
Fluphenazine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000469	0.00405	CcSEcCtD
Fluphenazine—CALM2—cardiovascular system—atherosclerosis	0.000469	0.0182	CbGeAlD
Fluphenazine—CALM1—cardiovascular system—atherosclerosis	0.000467	0.0181	CbGeAlD
Fluphenazine—Leukopenia—Pravastatin—atherosclerosis	0.000465	0.00401	CcSEcCtD
Fluphenazine—Hypertension—Pravastatin—atherosclerosis	0.000449	0.00387	CcSEcCtD
Fluphenazine—Dyspnoea—Lovastatin—atherosclerosis	0.000447	0.00386	CcSEcCtD
Fluphenazine—Mequitazine—HRH1—atherosclerosis	0.000442	0.079	CrCbGaD
Fluphenazine—Dry mouth—Niacin—atherosclerosis	0.000439	0.00379	CcSEcCtD
Fluphenazine—Dyspnoea—Ezetimibe—atherosclerosis	0.000439	0.00378	CcSEcCtD
Fluphenazine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000436	0.00376	CcSEcCtD
Fluphenazine—Decreased appetite—Lovastatin—atherosclerosis	0.000436	0.00376	CcSEcCtD
Fluphenazine—Anaphylactic shock—Niacin—atherosclerosis	0.000431	0.00372	CcSEcCtD
Fluphenazine—Constipation—Lovastatin—atherosclerosis	0.000429	0.0037	CcSEcCtD
Fluphenazine—Decreased appetite—Ezetimibe—atherosclerosis	0.000428	0.00369	CcSEcCtD
Fluphenazine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000424	0.00366	CcSEcCtD
Fluphenazine—Constipation—Ezetimibe—atherosclerosis	0.000421	0.00363	CcSEcCtD
Fluphenazine—Tachycardia—Niacin—atherosclerosis	0.00042	0.00363	CcSEcCtD
Fluphenazine—Pruritus—Rosuvastatin—atherosclerosis	0.000419	0.00361	CcSEcCtD
Fluphenazine—Skin disorder—Niacin—atherosclerosis	0.000418	0.00361	CcSEcCtD
Fluphenazine—Dyspnoea—Simvastatin—atherosclerosis	0.000418	0.00361	CcSEcCtD
Fluphenazine—ABCB1—blood vessel—atherosclerosis	0.000418	0.0162	CbGeAlD
Fluphenazine—CALM2—adipose tissue—atherosclerosis	0.000414	0.016	CbGeAlD
Fluphenazine—CALM1—adipose tissue—atherosclerosis	0.000412	0.0159	CbGeAlD
Fluphenazine—Decreased appetite—Simvastatin—atherosclerosis	0.000408	0.00352	CcSEcCtD
Fluphenazine—Hypotension—Niacin—atherosclerosis	0.000403	0.00347	CcSEcCtD
Fluphenazine—Constipation—Simvastatin—atherosclerosis	0.000401	0.00346	CcSEcCtD
Fluphenazine—Urticaria—Lovastatin—atherosclerosis	0.000398	0.00344	CcSEcCtD
Fluphenazine—Body temperature increased—Lovastatin—atherosclerosis	0.000397	0.00342	CcSEcCtD
Fluphenazine—HRH1—connective tissue—atherosclerosis	0.000391	0.0152	CbGeAlD
Fluphenazine—Urticaria—Ezetimibe—atherosclerosis	0.000391	0.00337	CcSEcCtD
Fluphenazine—Body temperature increased—Ezetimibe—atherosclerosis	0.000389	0.00335	CcSEcCtD
Fluphenazine—ADRA2A—connective tissue—atherosclerosis	0.000384	0.0149	CbGeAlD
Fluphenazine—Dyspnoea—Niacin—atherosclerosis	0.000384	0.00331	CcSEcCtD
Fluphenazine—Somnolence—Niacin—atherosclerosis	0.000383	0.0033	CcSEcCtD
Fluphenazine—Dyspnoea—Pravastatin—atherosclerosis	0.000378	0.00326	CcSEcCtD
Fluphenazine—Decreased appetite—Niacin—atherosclerosis	0.000374	0.00323	CcSEcCtD
Fluphenazine—Urticaria—Simvastatin—atherosclerosis	0.000373	0.00322	CcSEcCtD
Fluphenazine—Body temperature increased—Simvastatin—atherosclerosis	0.000371	0.0032	CcSEcCtD
Fluphenazine—Headache—Rosuvastatin—atherosclerosis	0.000371	0.0032	CcSEcCtD
Fluphenazine—Hypersensitivity—Lovastatin—atherosclerosis	0.00037	0.00319	CcSEcCtD
Fluphenazine—CALM3—liver—atherosclerosis	0.000369	0.0143	CbGeAlD
Fluphenazine—Decreased appetite—Pravastatin—atherosclerosis	0.000369	0.00318	CcSEcCtD
Fluphenazine—Zuclopenthixol—HRH1—atherosclerosis	0.000364	0.0652	CrCbGaD
Fluphenazine—Constipation—Pravastatin—atherosclerosis	0.000363	0.00313	CcSEcCtD
Fluphenazine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000362	0.00313	CcSEcCtD
Fluphenazine—Pruritus—Lovastatin—atherosclerosis	0.000355	0.00306	CcSEcCtD
Fluphenazine—Nausea—Rosuvastatin—atherosclerosis	0.000352	0.00303	CcSEcCtD
Fluphenazine—Pruritus—Ezetimibe—atherosclerosis	0.000348	0.003	CcSEcCtD
Fluphenazine—Hypersensitivity—Simvastatin—atherosclerosis	0.000346	0.00298	CcSEcCtD
Fluphenazine—Urticaria—Niacin—atherosclerosis	0.000342	0.00295	CcSEcCtD
Fluphenazine—Body temperature increased—Niacin—atherosclerosis	0.000341	0.00294	CcSEcCtD
Fluphenazine—Urticaria—Pravastatin—atherosclerosis	0.000337	0.00291	CcSEcCtD
Fluphenazine—Body temperature increased—Pravastatin—atherosclerosis	0.000335	0.00289	CcSEcCtD
Fluphenazine—Trazodone—HRH1—atherosclerosis	0.000335	0.06	CrCbGaD
Fluphenazine—Pruritus—Simvastatin—atherosclerosis	0.000332	0.00286	CcSEcCtD
Fluphenazine—CYP2E1—cardiovascular system—atherosclerosis	0.000327	0.0127	CbGeAlD
Fluphenazine—HTR2A—connective tissue—atherosclerosis	0.000327	0.0127	CbGeAlD
Fluphenazine—Hypersensitivity—Niacin—atherosclerosis	0.000317	0.00274	CcSEcCtD
Fluphenazine—Headache—Lovastatin—atherosclerosis	0.000314	0.00271	CcSEcCtD
Fluphenazine—Thiothixene—HRH1—atherosclerosis	0.000314	0.0562	CrCbGaD
Fluphenazine—Hypersensitivity—Pravastatin—atherosclerosis	0.000313	0.0027	CcSEcCtD
Fluphenazine—Mesoridazine—HRH1—atherosclerosis	0.00031	0.0555	CrCbGaD
Fluphenazine—Headache—Ezetimibe—atherosclerosis	0.000308	0.00266	CcSEcCtD
Fluphenazine—Pruritus—Niacin—atherosclerosis	0.000305	0.00263	CcSEcCtD
Fluphenazine—HRH1—adipose tissue—atherosclerosis	0.0003	0.0116	CbGeAlD
Fluphenazine—Prochlorperazine—HRH1—atherosclerosis	0.0003	0.0537	CrCbGaD
Fluphenazine—Pruritus—Pravastatin—atherosclerosis	0.0003	0.00259	CcSEcCtD
Fluphenazine—Nausea—Lovastatin—atherosclerosis	0.000298	0.00257	CcSEcCtD
Fluphenazine—ADRA2A—adipose tissue—atherosclerosis	0.000295	0.0114	CbGeAlD
Fluphenazine—Headache—Simvastatin—atherosclerosis	0.000294	0.00254	CcSEcCtD
Fluphenazine—Nausea—Ezetimibe—atherosclerosis	0.000292	0.00252	CcSEcCtD
Fluphenazine—CALM2—liver—atherosclerosis	0.00029	0.0112	CbGeAlD
Fluphenazine—CALM1—liver—atherosclerosis	0.000289	0.0112	CbGeAlD
Fluphenazine—HTR2A—cardiovascular system—atherosclerosis	0.000284	0.011	CbGeAlD
Fluphenazine—Nausea—Simvastatin—atherosclerosis	0.000279	0.0024	CcSEcCtD
Fluphenazine—Headache—Niacin—atherosclerosis	0.00027	0.00233	CcSEcCtD
Fluphenazine—Headache—Pravastatin—atherosclerosis	0.000266	0.00229	CcSEcCtD
Fluphenazine—Propiomazine—HRH1—atherosclerosis	0.000261	0.0467	CrCbGaD
Fluphenazine—Nausea—Niacin—atherosclerosis	0.000256	0.00221	CcSEcCtD
Fluphenazine—Nausea—Pravastatin—atherosclerosis	0.000252	0.00217	CcSEcCtD
Fluphenazine—Thioridazine—HRH1—atherosclerosis	0.000234	0.0419	CrCbGaD
Fluphenazine—CYP1A2—liver—atherosclerosis	0.000225	0.00871	CbGeAlD
Fluphenazine—Methotrimeprazine—HRH1—atherosclerosis	0.000223	0.04	CrCbGaD
Fluphenazine—Trifluoperazine—HRH1—atherosclerosis	0.000217	0.0388	CrCbGaD
Fluphenazine—Perphenazine—HRH1—atherosclerosis	0.000215	0.0384	CrCbGaD
Fluphenazine—Quetiapine—HRH1—atherosclerosis	0.00021	0.0377	CrCbGaD
Fluphenazine—CYP2E1—liver—atherosclerosis	0.000202	0.00784	CbGeAlD
Fluphenazine—Promazine—HRH1—atherosclerosis	0.000194	0.0346	CrCbGaD
Fluphenazine—ABCB1—cardiovascular system—atherosclerosis	0.000186	0.00722	CbGeAlD
Fluphenazine—HTR2A—liver—atherosclerosis	0.000176	0.00681	CbGeAlD
Fluphenazine—Chlorpromazine—HRH1—atherosclerosis	0.00017	0.0305	CrCbGaD
Fluphenazine—ABCB1—adipose tissue—atherosclerosis	0.000164	0.00636	CbGeAlD
Fluphenazine—CYP2D6—liver—atherosclerosis	0.00016	0.00621	CbGeAlD
Fluphenazine—ABCB1—liver—atherosclerosis	0.000115	0.00446	CbGeAlD
Fluphenazine—Acepromazine—ALB—atherosclerosis	7.54e-05	0.0135	CrCbGaD
Fluphenazine—Thioproperazine—ALB—atherosclerosis	7.37e-05	0.0132	CrCbGaD
Fluphenazine—Pipotiazine—ALB—atherosclerosis	7.25e-05	0.013	CrCbGaD
Fluphenazine—Thiothixene—ALB—atherosclerosis	7.25e-05	0.013	CrCbGaD
Fluphenazine—Chlorpromazine—ALB—atherosclerosis	3.93e-05	0.00704	CrCbGaD
Fluphenazine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.09e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	4.09e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—AKT1—atherosclerosis	4.08e-06	3.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—F2—atherosclerosis	4.07e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—F2—atherosclerosis	4.07e-06	3.24e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOE—atherosclerosis	4.04e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ALB—atherosclerosis	4.04e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ALB—atherosclerosis	4.04e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	4.04e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MAPK8—atherosclerosis	4.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOB—atherosclerosis	4.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	4.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CG—atherosclerosis	4.03e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—NOS3—atherosclerosis	4.02e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.02e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARA—atherosclerosis	4.02e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—atherosclerosis	4.01e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CAV1—atherosclerosis	4.01e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—NOS3—atherosclerosis	4e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOA1—atherosclerosis	4e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	3.99e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	3.97e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NFKB1—atherosclerosis	3.97e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NFKB1—atherosclerosis	3.97e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—AKT1—atherosclerosis	3.95e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—AKT1—atherosclerosis	3.95e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	3.93e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.92e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—AKT1—atherosclerosis	3.92e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	3.91e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	3.91e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MAPK8—atherosclerosis	3.9e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MAPK8—atherosclerosis	3.9e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	3.9e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	3.9e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AGT—atherosclerosis	3.89e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—NOS3—atherosclerosis	3.87e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—NOS3—atherosclerosis	3.87e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	3.87e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	3.86e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—atherosclerosis	3.85e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—LPL—atherosclerosis	3.85e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	3.84e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—STAT3—atherosclerosis	3.82e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—INS—atherosclerosis	3.81e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOE—atherosclerosis	3.81e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—AKT1—atherosclerosis	3.79e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—AKT1—atherosclerosis	3.79e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.78e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.77e-06	3e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.76e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—atherosclerosis	3.75e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	3.74e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	3.73e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	3.73e-06	2.97e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	3.72e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	3.7e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	3.69e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—STAT3—atherosclerosis	3.69e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—INS—atherosclerosis	3.69e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—INS—atherosclerosis	3.69e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IGF1—atherosclerosis	3.69e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	3.68e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.68e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	3.66e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CD36—atherosclerosis	3.66e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—atherosclerosis	3.66e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.65e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	3.65e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	3.64e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	3.63e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—atherosclerosis	3.63e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—atherosclerosis	3.63e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	3.63e-06	2.89e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	3.62e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	3.61e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	3.58e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	3.57e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—STAT3—atherosclerosis	3.57e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—STAT3—atherosclerosis	3.57e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IGF1—atherosclerosis	3.57e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IGF1—atherosclerosis	3.57e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.56e-06	2.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—atherosclerosis	3.54e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—atherosclerosis	3.54e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	3.54e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MAPK3—atherosclerosis	3.52e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PPARG—atherosclerosis	3.52e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	3.51e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	3.5e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.47e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—INS—atherosclerosis	3.46e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	3.45e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	3.45e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.44e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.44e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MAPK3—atherosclerosis	3.41e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MAPK3—atherosclerosis	3.41e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—STAT3—atherosclerosis	3.41e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.4e-06	2.71e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	3.4e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.39e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	3.39e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	3.39e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	3.36e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NOS3—atherosclerosis	3.34e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	3.34e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	3.33e-06	2.65e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.32e-06	2.64e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	3.31e-06	2.63e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AGT—atherosclerosis	3.3e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—STAT3—atherosclerosis	3.29e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—STAT3—atherosclerosis	3.29e-06	2.62e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	3.28e-06	2.61e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—INS—atherosclerosis	3.26e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK3—atherosclerosis	3.25e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.25e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	3.25e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NOS3—atherosclerosis	3.23e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NOS3—atherosclerosis	3.23e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	3.23e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—atherosclerosis	3.23e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.22e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.2e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	3.2e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	3.19e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.19e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.19e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	3.18e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	3.18e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—atherosclerosis	3.17e-06	2.52e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	3.16e-06	2.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—atherosclerosis	3.16e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK3—atherosclerosis	3.15e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK3—atherosclerosis	3.15e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	3.14e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	3.14e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—atherosclerosis	3.14e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.14e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	3.13e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.13e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	3.09e-06	2.46e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	3.08e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	3.07e-06	2.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—atherosclerosis	3.05e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—atherosclerosis	3.05e-06	2.43e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—atherosclerosis	3.03e-06	2.41e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—atherosclerosis	2.98e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—atherosclerosis	2.97e-06	2.36e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	2.95e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	2.94e-06	2.34e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	2.92e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.91e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	2.91e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	2.9e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.9e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—atherosclerosis	2.89e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	2.87e-06	2.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—atherosclerosis	2.87e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—atherosclerosis	2.87e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.87e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	2.86e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.86e-06	2.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	2.85e-06	2.27e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—atherosclerosis	2.82e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.81e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	2.79e-06	2.22e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—atherosclerosis	2.77e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—INS—atherosclerosis	2.76e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	2.74e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.74e-06	2.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—atherosclerosis	2.73e-06	2.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—atherosclerosis	2.73e-06	2.17e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	2.71e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—atherosclerosis	2.7e-06	2.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—atherosclerosis	2.68e-06	2.14e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—atherosclerosis	2.67e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	2.66e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.66e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NFKB1—atherosclerosis	2.65e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	2.64e-06	2.1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	2.61e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.61e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK8—atherosclerosis	2.61e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—atherosclerosis	2.6e-06	2.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—atherosclerosis	2.59e-06	2.07e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—atherosclerosis	2.59e-06	2.07e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—atherosclerosis	2.58e-06	2.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NFKB1—atherosclerosis	2.57e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NFKB1—atherosclerosis	2.57e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—atherosclerosis	2.53e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK8—atherosclerosis	2.52e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK8—atherosclerosis	2.52e-06	2.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—atherosclerosis	2.52e-06	2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—atherosclerosis	2.52e-06	2e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.5e-06	1.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—atherosclerosis	2.49e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—atherosclerosis	2.49e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	2.49e-06	1.98e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—atherosclerosis	2.46e-06	1.96e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.42e-06	1.93e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.42e-06	1.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—atherosclerosis	2.41e-06	1.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—atherosclerosis	2.38e-06	1.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—atherosclerosis	2.38e-06	1.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—atherosclerosis	2.38e-06	1.89e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—atherosclerosis	2.33e-06	1.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—atherosclerosis	2.33e-06	1.85e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—atherosclerosis	2.32e-06	1.85e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	2.31e-06	1.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—atherosclerosis	2.31e-06	1.84e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—atherosclerosis	2.31e-06	1.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—atherosclerosis	2.3e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—atherosclerosis	2.3e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—atherosclerosis	2.3e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—atherosclerosis	2.3e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—atherosclerosis	2.28e-06	1.81e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.21e-06	1.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—atherosclerosis	2.21e-06	1.76e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—atherosclerosis	2.2e-06	1.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—atherosclerosis	2.2e-06	1.75e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—atherosclerosis	2.19e-06	1.75e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	2.14e-06	1.71e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—atherosclerosis	2.14e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—atherosclerosis	2.14e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2.13e-06	1.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—atherosclerosis	2.12e-06	1.69e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—atherosclerosis	2.12e-06	1.69e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—atherosclerosis	2.04e-06	1.62e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.01e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	2.01e-06	1.6e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—atherosclerosis	2e-06	1.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	1.88e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	1.85e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—atherosclerosis	1.85e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.85e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—atherosclerosis	1.84e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	1.83e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—atherosclerosis	1.78e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—atherosclerosis	1.78e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.68e-06	1.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—atherosclerosis	1.67e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—atherosclerosis	1.61e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—atherosclerosis	1.61e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—atherosclerosis	1.54e-06	1.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—atherosclerosis	1.49e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—atherosclerosis	1.49e-06	1.18e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—atherosclerosis	1.39e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.31e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.11e-06	8.85e-06	CbGpPWpGaD
